F Killander1, P Karlsson2, H Anderson3, J Mattsson4, E Holmberg5, D Lundstedt2, L Holmberg6, P Malmström7. 1. Department of Clinical Sciences, Oncology, Lund University, Lund, Sweden; Skåne Department of Oncology, Skåne University Hospital, Lund, Sweden. Electronic address: fredrika.killander@med.lu.se. 2. Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, Sahlgrenska University Hospital, Göteborg, Sweden. 3. Department of Clinical Sciences, Cancer Epidemiology, Lund, Sweden. 4. Department of Surgery, Sahlgrenska University Hospital, Göteborg, Sweden. 5. Regional Oncologic Centre, Sahlgrenska University Hospital, Göteborg, Sweden. 6. Regional Oncologic Centre, Uppsala University Hospital, Uppsala, Sweden; King's College London, Faculty of Life Sciences and Medicine, Division of Cancer Studies, London, UK. 7. Department of Clinical Sciences, Oncology, Lund University, Lund, Sweden; Skåne Department of Oncology, Skåne University Hospital, Lund, Sweden.
Abstract
BACKGROUND:Breast-conserving surgery (BCS) followed by radiotherapy (RT) is an established treatment for women with T1-2N0 breast cancers. Since subgroups of patients have low ipsilateral breast tumour recurrence (IBTR) rates, it is important to study whether RT is necessary for all patients. PATIENTS AND METHODS: A total of 1187 women with primary T1-2N0M0 breast cancer were randomised, after standardised sector resection, to postoperative whole breast RT or no local treatment. Adjuvant systemic therapy was offered to patients with stage II cancers. Patients were followed with clinical examinations and annual mammography for 10 years and thereafter referred to the Swedish mammography screening program. RESULTS: After 15 years of follow-up, a higher cumulative incidence of IBTR was observed in control patients, 23.9%, versus irradiated patients, 11.5%, P<0.001. Recurrence-free survival was inferior, 51.7% versus 60.4%, P=0.0013. The main effect of RT was seen during the first 5 years. However, overall survival was not significantly lower 68.4% versus 71.1%, P=0.68, nor was breast cancer-specific mortality significantly higher. CONCLUSIONS: RT after BCS significantly reduced the incidence of IBTR at 15 years of follow-up. We were unable to identify subgroups which could be spared RT. Breast cancer mortality was not significantly reduced after RT. Good predictive markers for radiation sensitivity and improved adjuvant systemic therapy are needed to omit RT after BCS.
RCT Entities:
BACKGROUND: Breast-conserving surgery (BCS) followed by radiotherapy (RT) is an established treatment for women with T1-2N0 breast cancers. Since subgroups of patients have low ipsilateral breast tumour recurrence (IBTR) rates, it is important to study whether RT is necessary for all patients. PATIENTS AND METHODS: A total of 1187 women with primary T1-2N0M0 breast cancer were randomised, after standardised sector resection, to postoperative whole breast RT or no local treatment. Adjuvant systemic therapy was offered to patients with stage II cancers. Patients were followed with clinical examinations and annual mammography for 10 years and thereafter referred to the Swedish mammography screening program. RESULTS: After 15 years of follow-up, a higher cumulative incidence of IBTR was observed in control patients, 23.9%, versus irradiated patients, 11.5%, P<0.001. Recurrence-free survival was inferior, 51.7% versus 60.4%, P=0.0013. The main effect of RT was seen during the first 5 years. However, overall survival was not significantly lower 68.4% versus 71.1%, P=0.68, nor was breast cancer-specific mortality significantly higher. CONCLUSIONS: RT after BCS significantly reduced the incidence of IBTR at 15 years of follow-up. We were unable to identify subgroups which could be spared RT. Breast cancer mortality was not significantly reduced after RT. Good predictive markers for radiation sensitivity and improved adjuvant systemic therapy are needed to omit RT after BCS.
Keywords:
Breast cancer; Breast-conserving surgery; Contralateral breast cancer; Ipsilateral breast tumour recurrence; Randomised trial; Whole breast radiation
Authors: Martin Sjöström; Johan Staaf; Patrik Edén; Fredrik Wärnberg; Jonas Bergh; Per Malmström; Mårten Fernö; Emma Niméus; Irma Fredriksson Journal: Breast Cancer Res Date: 2018-07-04 Impact factor: 6.466
Authors: Martin Sjöström; S Laura Chang; Nick Fishbane; Elai Davicioni; Shuang G Zhao; Linda Hartman; Erik Holmberg; Felix Y Feng; Corey W Speers; Lori J Pierce; Per Malmström; Mårten Fernö; Per Karlsson Journal: J Clin Oncol Date: 2019-10-16 Impact factor: 44.544
Authors: Pierfrancesco Franco; Fiorenza De Rose; Maria Carmen De Santis; Nadia Pasinetti; Valentina Lancellotta; Bruno Meduri; Icro Meattini Journal: Clin Transl Radiat Oncol Date: 2020-02-08